Combating BRD With Zelnate

There are several effective antibiotics and vaccines to help combat bovine respiratory disease, or BRD, it remains an ongoing battle and costs the industry more than $1 Bayerbillion annually in the United States alone.

Bayer’s Dr. Larry Hawkins tells us about a fairly new product on the market, Zelnate® DNA Immunostimulant, a new innovation in animal health that changes the way veterinarians and producers are able to approach BRD.

Video : An overview of the impact of BRD on the cattle industry and how Zelnate® DNA Immunostimulant fits into the ongoing battle against the disease.

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s